Low Dose Computed Tomography for Lung Cancer Screening
This study will evaluate the impact of a proactive, EHR-supported enrollment strategy that links LDCT-eligible smokers with an evidence-based intervention comprised of a web-based program and integrated text messaging. The goal is to provide actionable findings about how to most effectively and cost efficiently promote abstinence in LDCT clinics.
Checked against the public recordLast updated Aug 29, 2019 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Mayo Clinic
- Interventions being studied
- Behavioral: Usual Care; Behavioral: WEB+TXT; Behavioral: WEB+TXT+TTS
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. Scheduled for LDCT screening 2. Current smoking (every day/some days) 3. At least weekly use of the Internet 4. Current ownership of cell phone with a text messaging plan 5. Willing to receive study text messages. 6. Ability to complete all aspects of the study 7. Ability to provide signed informed consent Exclusion Criteria: 1. Current (in the past 30 days) use of tobacco cessation medication or participation in tobacco cessation treatment. 2. Those with a condition deemed by the investigators to be exclusionary to the study
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Mayo ClinicRochester, Minnesota
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 29, 2019. Always confirm current availability with the study team.